Affinity Asset Advisors »

Anaptysbio Inc Common shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.7M 200k 33.50

More positions owned by Affinity Asset Advisors

Xenon Pharmaceuticals (XENE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Cassava Sciences Put Option (SAVA)
Apogee Therapeutics (APGE)
Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Vera Therapeutics Cl A (VERA)
Verona Pharma Sponsored Ads (VRNA)
Autolus Therapeutics Spon Ads (AUTL)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Inozyme Pharma (INZY)

View all positions for Affinity Asset Advisors

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
Frazier Life Sciences Management
BlackRock
BlackRock
Vanguard Group
Tang Capital Management
Boxer Capital
State Street Corporation
First Light Asset Management
T. Rowe Price Associates
Palo Alto Investors
Ikarian Capital
Assenagon Asset Management
Geode Capital Management
Woodline Partners

View all funds holding Anaptysbio Inc Common